Bg pattern

MONTELUKAST RATIOPHARM 5 mg CHEWABLE TABLETS

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use MONTELUKAST RATIOPHARM 5 mg CHEWABLE TABLETS

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the User

Montelukast ratiopharm 5 mg Chewable Tablets EFG

For children from 6 to 14 years of age

Read the entire package leaflet carefully before you or your child start taking this medicine, as it contains important information.

  • Keep this package leaflet, as you may need to read it again.
  • If you have any further questions, ask your doctor or your child's doctor or pharmacist.
  • This medicine has been prescribed for you or your child only. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours or your child's.
  • If you or your child experience any side effects, talk to your doctor or your child's doctor or pharmacist. This includes any possible side effects not listed in this package leaflet. See section 4.

Contents of the package leaflet

  1. What Montelukast ratiopharm 5 mg Chewable Tablets are and what they are used for
  2. What you need to know before you or your child take Montelukast ratiopharm 5 mg Chewable Tablets
  3. How to take Montelukast ratiopharm 5 mg Chewable Tablets
  4. Possible side effects
  5. Storage of Montelukast ratiopharm 5 mg Chewable Tablets
  6. Packaging and additional information

1. What Montelukast ratiopharm 5 mg Chewable Tablets are and what they are used for

What Montelukast ratiopharm 5 mg Chewable Tablets are

Montelukast ratiopharm 5 mg Chewable Tablets are a leukotriene receptor antagonist that blocks substances called leukotrienes.

How Montelukast ratiopharm 5 mg Chewable Tablets work

Leukotrienes cause narrowing and swelling of the airways in the lungs. By blocking leukotrienes, Montelukast ratiopharm 5 mg Chewable Tablets improve asthma symptoms and help control the disease.

When to use Montelukast ratiopharm 5 mg Chewable Tablets

Your doctor has prescribed Montelukast ratiopharm 5 mg Chewable Tablets to treat asthma and prevent asthma symptoms during the day and night.

  • Montelukast ratiopharm 5 mg Chewable Tablets are used for the treatment of pediatric patients from 6 to 14 years of age who are not adequately controlled with their medication and need additional treatment.
  • Montelukast ratiopharm 5 mg Chewable Tablets are also used as an alternative treatment to inhaled corticosteroids in patients between 6 and 14 years of age who have not recently taken oral corticosteroids for the treatment of their asthma and have demonstrated that they are unable to use inhaled corticosteroids.
  • Montelukast ratiopharm 5 mg Chewable Tablets also help prevent narrowing of the airways caused by exercise.

Depending on the symptoms and severity of your or your child's asthma, your doctor will determine how to use Montelukast ratiopharm 5 mg Chewable Tablets.

What is asthma?

Asthma is a chronic disease.

Asthma includes:

  • difficulty breathing due to narrowing of the airways. This narrowing of the airways worsens and improves in response to various diseases.
  • airways that are sensitive and react to many things, such as cigarette smoke, pollen, cold air, or exercise.
  • swelling (inflammation) of the inner layer of the airways.

Asthma symptoms include: coughing, wheezing, and chest congestion.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before you or your child take Montelukast ratiopharm 5 mg Chewable Tablets

Tell your child's doctor about any allergy or medical problem that your child has now or has had.

Do not take/give Montelukast ratiopharm 5 mg Chewable Tablets:

  • If you or your child are allergic to montelukast or any of the other ingredients of this medicine (listed in section 6).

Warnings and precautions

Consult your child's doctor or pharmacist before you or your child take Montelukast ratiopharm 5 mg Chewable Tablets.

  • If your or your child's asthma or breathing worsens, inform your doctor immediately.
  • Montelukast ratiopharm 5 mg Chewable Tablets are not indicated for the treatment of acute asthma attacks. If an attack occurs, follow the instructions given by your doctor for you or your child. Always have your child's rescue inhaler medication available for asthma attacks.
  • It is essential that you or your child use all asthma medications prescribed by your doctor. Montelukast ratiopharm should not be used in place of other asthma medications that your doctor has prescribed for your child.
  • Some patients treated with asthma medications should be aware that if they develop a combination of symptoms such as flu-like illness, tingling or numbness of arms or legs, worsening of lung symptoms, and/or skin rash, they should consult their doctor.
  • You or your child should not take aspirin or non-steroidal anti-inflammatory drugs (also known as non-steroidal anti-inflammatory medications or NSAIDs) if they worsen your or your child's asthma.

Several neuropsychiatric events (e.g., changes in behavior and mood-related, depression, and suicidal tendencies) have been reported in patients of all ages treated with montelukast (see section 4). If your child develops these symptoms while taking Montelukast ratiopharm 5 mg, you should consult your doctor.

Children and adolescents

Do not give this medicine to children under 6 years of age.

For pediatric patients under 18 years of age, other presentations of this medicine are available based on the age range.

Taking Montelukast ratiopharm 5 mg Chewable Tablets with other medicines

Tell your child's doctor or pharmacist if your child is taking/using, has recently taken/used, or might take/use any other medicines, including those obtained without a prescription.

Some medicines may affect the way Montelukast ratiopharm 5 mg Chewable Tablets work, or montelukast may affect the way other medicines work.

Before taking Montelukast ratiopharm 5 mg Chewable Tablets, tell your doctor if you or your child are taking the following medicines:

  • phenobarbital (used to treat epilepsy).
  • phenytoin (used to treat epilepsy).
  • rifampicin (used to treat tuberculosis and some other infections).
  • gemfibrozil (used to treat hypertriglyceridemia, hyperlipidemia, and primary hypercholesterolemia).

Taking Montelukast ratiopharm 5 mg Chewable Tablets with food and drinks

If Montelukast ratiopharm 5 mg Chewable Tablets should not be taken immediately with meals, they should be taken in the evening, 1 hour before or 2 hours after food.

Pregnancy, breastfeeding, and fertility

If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.

Pregnancy

Your doctor will assess whether you can take montelukast during this period.

Breastfeeding

It is not known whether montelukast appears in breast milk. If you are breastfeeding or plan to breastfeed, you should consult your doctor before taking Montelukast ratiopharm.

Driving and using machines

Montelukast ratiopharm 5 mg is not expected to affect your ability to drive a car or operate machinery. However, individual responses to the medicine may vary. Certain side effects (such as dizziness and somnolence) that have been reported with montelukast may affect the patient's ability to drive or operate machinery.

Montelukast ratiopharm contains aspartame

This medicine contains 0.5 mg of aspartame in each chewable tablet.

Aspartame is a source of phenylalanine, which may be harmful in cases of phenylketonuria (PKU), a rare genetic disorder in which phenylalanine accumulates because the body is unable to eliminate it properly.

Montelukast ratiopharm contains sodium

This medicine contains less than 23 mg of sodium (1 mmol) per chewable tablet; this is essentially "sodium-free".

3. How to take Montelukast ratiopharm 5 mg Chewable Tablets

Follow exactly the administration instructions of this medicine given by your doctor or pharmacist for you or your child. In case of doubt, consult your doctor or pharmacist again.

  • You or your child should only take one chewable tablet of montelukast once a day, as prescribed by your doctor.
  • It should be taken even when you or your child do not have symptoms or when you or your child have an acute asthma attack.

For children from 6 to 14 years of age

The recommended dose is one 5 mg chewable tablet daily, which should be taken in the evening.

If you or your child are taking Montelukast ratiopharm 5 mg Chewable Tablets, make sure that neither you nor your child take any other product that contains the same active ingredient, montelukast.

This medicine is taken orally.

The tablets should be chewed before swallowing.

Montelukast ratiopharm 5 mg Chewable Tablets should not be taken with food; they should be taken at least 1 hour before or 2 hours after food.

For children from 2 to 5 years of age, 4 mg chewable tablets are available.

For children from 2 to 5 years of age, with difficulty taking the chewable tablet, a 4 mg granule formulation is available.

For patients 15 years of age and older, 10 mg film-coated tablets are available.

If you or your child take more Montelukast ratiopharm 5 mg Chewable Tablets than you should

Seek immediate medical attention from your doctor.

In most cases of overdose, no adverse effects were reported. The symptoms that occurred most frequently in overdose in adults and children were abdominal pain, somnolence, thirst, headache, vomiting, and hyperactivity.

Bring this package leaflet, the remaining tablets, and the packaging to the hospital or doctor so they know how many tablets were consumed.

You can also immediately consult your pharmacist or call the Toxicology Information Service, telephone 91 562 04 20, indicating the medicine and the amount ingested.

If you or your child forget to take Montelukast ratiopharm 5 mg Chewable Tablets

Try to take/give montelukast as prescribed. However, if you or your child forget a dose, just resume the usual routine of one chewable tablet once a day.

Do not take/give a double dose to make up for forgotten doses.

If you or your child stop taking Montelukast ratiopharm 5 mg Chewable Tablets

Montelukast ratiopharm 5 mg Chewable Tablets can only treat your or your child's asthma if you or your child continue taking it. It is essential that you or your child continue taking this medicine for as long as your doctor or your child's doctor prescribes it. It will help control your or your child's asthma.

If you have any further questions about the use of this medicine, ask your doctor or pharmacist.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

In clinical trials with montelukast 5 mg chewable tablets, the adverse reactions related to the administration of the medicine and reported most frequently (may affect up to 1 in 10 people) were:

  • headache
  • abdominal pain
  • thirst

These side effects were generally mild and occurred more frequently in patients treated with montelukast than with placebo (a tablet that does not contain medicine).

Severe side effects

Consult your doctor immediatelyif you observe any of the following side effects, which may be severe and you or your child may need urgent medical treatment.

Uncommon (may affect up to 1 in 100 people):

  • allergic reactions that include swelling of the face, lips, tongue, and/or throat that can cause difficulty breathing or swallowing
  • behavior and mood-related changes: excitement including aggressive or hostile behavior, depression
  • seizures

Rare (may affect up to 1 in 1,000 people):

  • increased risk of bleeding
  • tremor
  • palpitations

Very rare (may affect up to 1 in 10,000 people):

  • a combination of symptoms such as flu-like illness, tingling or numbness of arms and legs, worsening of lung symptoms, and/or skin rash (Churg-Strauss syndrome) (see section 2)
  • low platelet count
  • behavior and mood-related changes: hallucinations, disorientation, uncontrolled muscle movements
  • inflammation (inflammation) of the lungs
  • severe skin reactions (erythema multiforme) that can occur without warning
  • inflammation of the liver (hepatitis)

Other side effects reported during the marketing of the medicine

Very common (may affect more than 1 in 10 people)

  • upper respiratory tract infections

Common (may affect up to 1 in 10 people)

  • diarrhea, nausea, and vomiting
  • fever
  • skin rash
  • increase in liver enzyme levels

Uncommon (may affect up to 1 in 100 people)

  • behavior and mood-related changes: sleep disturbances, including nightmares, sleep problems, sleepwalking, irritability, anxiety, agitation
  • dizziness, somnolence, tingling/numbness of the extremities
  • nosebleeds, dry mouth
  • indigestion
  • bruising, itching, hives
  • muscle or joint pain, muscle cramps
  • weakness, fatigue, feeling of general malaise, swelling

Rare (may affect up to 1 in 1,000 people)

  • behavior and mood-related changes: attention disturbance, memory disturbance, uncontrolled muscle movements

Very rare (may affect up to 1 in 10,000 patients)

  • red, painful lumps under the skin, which most frequently appear on the shins (erythema nodosum)
  • behavior and mood-related changes: attention disturbance, memory disturbance, uncontrolled muscle movements

Reporting of side effects

If you or your child experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this package leaflet. You can also report side effects directly through the Spanish Pharmacovigilance System for Human Use Medicines: http://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Montelukast ratiopharm 5 mg Chewable Tablets

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date stated on the packaging and blister after CAD or EXP. The expiry date is the last day of the month indicated.

Do not store above 25°C. Store in the original packaging to protect from light.

Do not use this medicine if you notice visible signs of deterioration.

Medicines should not be disposed of via wastewater or household waste. Place the packaging and any unused medicine in the SIGRE collection point at the pharmacy. Ask your pharmacist how to dispose of the packaging and any unused medicine. This will help protect the environment.

6. Packaging Contents and Additional Information

Composition of Montelukast ratiopharm 5 mg Chewable Tablets

  • The active ingredient is montelukast. Each chewable tablet contains 5.20 mg of montelukast sodium, which is equivalent to 5 mg of montelukast.
  • The other components are: mannitol (E421), sodium lauryl sulfate, hydroxypropylcellulose, red iron oxide (E172), cherry flavor PHS-143671: maltodextrins (corn) and modified starch E1450, aspartame (E951), sodium glycolate starch Type A (derived from potato) and magnesium stearate.

Appearance of the Product and Packaging Contents

The 5 mg chewable tablets are mottled pink, square-shaped tablets, engraved with "93" on one side and "7425" on the other.

Montelukast ratiopharm 5 mg chewable tablets are available in packs of 7, 10, 14, 15, 20, 28, 30, 50, 56, 60, 90, 98 and 100 tablets.

Aluminum-Aluminum blister packs.

Only some pack sizes may be marketed.

Marketing Authorization Holder

Teva Pharma, S.L.U.

Anabel Segura 11, Edificio Albatros B 1st floor

28108 Alcobendas, Madrid

Spain

Manufacturer

Teva Operations Poland Sp.z.o.o.

Mogilska 80, Krakow- 31-546 -

Poland

or

Merckle GmbH

Ludwig-Merckle-Str. 3, 89143 Blaubeuren

Germany

or

Pharmachemie B.V.

Swensweg 5, 2031 GA Haarlem

Netherlands

or

TEVA Pharmaceutical Works Private Limited Company

Pallagi út 13, 4042 Debrecen

Hungary

or

TEVA PHARMA S.L.U.

C/C, n. 4, Poligono Industrial Malpica, 50016 Zaragoza

Spain

This medicinal product is authorized in the Member States of the European Economic Area under the following names:

Portugal: Montelucaste ratiopharm

Spain: Montelukast ratiopharm 5 mg chewable tablets EFG

Date of the last revision of this leaflet: August 2024

Detailed information on this medicinal product is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/

Online doctors for MONTELUKAST RATIOPHARM 5 mg CHEWABLE TABLETS

Discuss questions about MONTELUKAST RATIOPHARM 5 mg CHEWABLE TABLETS, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (25)
Doctor

Lina Travkina

Family medicine 13 years exp.

Dr. Lina Travkina is a licensed family and preventive medicine doctor based in Italy. She provides online consultations for adults and children, supporting patients across all stages of care – from acute symptom management to long-term health monitoring and prevention.

Areas of medical care include:

  • Respiratory conditions: colds, flu, acute and chronic bronchitis, mild to moderate pneumonia, bronchial asthma.
  • ENT and eye conditions: sinusitis, tonsillitis, pharyngitis, otitis, infectious and allergic conjunctivitis.
  • Digestive issues: gastritis, acid reflux (GERD), IBS, dyspepsia, bloating, constipation, diarrhoea, functional bowel symptoms, intestinal infections.
  • Urological and infectious diseases: acute and recurrent cystitis, bladder and kidney infections, prevention of recurrent UTIs, asymptomatic bacteriuria.
  • Chronic conditions: hypertension, diabetes, hypercholesterolemia, metabolic syndrome, thyroid disorders, excess weight.
  • Neurological and general symptoms: headache, migraine, dizziness, fatigue, sleep disturbances, reduced concentration, anxiety, asthenia.
  • Chronic pain support: back, neck, joint, and muscle pain, tension syndromes, pain associated with osteochondrosis and chronic conditions.

Additional care areas:

  • Preventive consultations and check-up planning.
  • Medical advice and follow-up consultations.
  • Test interpretation and diagnostic guidance.
  • Structured support for undiagnosed complaints.
  • Second opinion on diagnoses and treatment plans.
  • Nutritional and lifestyle support for vitamin deficiencies, anaemia, metabolic issues.
  • Post-operative recovery support and pain management.
  • Preconception counselling and postpartum support.
  • Immunity support and strategies to reduce frequency of infections.

Dr. Travkina combines evidence-based medicine with an attentive, personalised approach. Her consultations focus not only on treatment, but also on prevention, recovery, and long-term wellbeing.

If during the consultation it becomes clear that your case requires in-person assessment or specialised care outside of her scope, the session will be terminated and the payment fully refunded.

Camera Book a video appointment
€70
5.0 (808)
Doctor

Alina Tsurkan

Family medicine 13 years exp.

Dr. Alina Tsurkan is a licensed family medicine physician based in Portugal, offering online consultations for adults and children. She provides professional primary care, with a focus on prevention, accurate diagnosis, and long-term management of acute and chronic conditions.

Dr. Tsurkan supports patients with a wide range of health issues, including:

  • Respiratory infections: cold, flu, bronchitis, pneumonia, and lingering coughs.
  • ENT conditions: sinusitis, tonsillitis, otitis (ear infections), sore throat, allergic rhinitis.
  • Eye conditions: allergic or infectious conjunctivitis, red eyes, irritation.
  • Digestive issues: acid reflux (GERD), gastritis, irritable bowel syndrome (IBS), constipation, bloating, nausea.
  • Urinary and reproductive health: urinary tract infections (UTIs), cystitis, prevention of recurrent infections.
  • Chronic diseases: hypertension, elevated cholesterol, weight management.
  • Neurological complaints: headaches, migraines, sleep disturbances, fatigue, general weakness.
  • Children’s health: fever, infections, digestive issues, follow-ups, vaccination guidance.

She also provides:

  • IMT medical certificates for driving licence exchange in Portugal.
  • Personalised preventive care and wellness consultations.
  • Interpretation of test results and medical reports.
  • Follow-up care and medication review.
  • Support in managing multiple coexisting conditions.
  • Remote prescription management and medical documentation.

Dr. Tsurkan’s approach is evidence-based and holistic. She works closely with each patient to develop an individualised care plan that addresses both symptoms and root causes. Her goal is to empower patients to take control of their health and maintain well-being through lifestyle adjustments, routine check-ups, and early intervention.

Camera Book a video appointment
€55
0.0 (0)
Doctor

Hocine Lokchiri

General medicine 21 years exp.

Dr. Hocine Lokchiri is a French consultant with over 20 years of experience in General and Emergency Medicine. He works with adults and children, helping patients with urgent symptoms, infections, sudden health changes and everyday medical concerns that require timely evaluation. His background includes clinical practice in France, Switzerland and the United Arab Emirates, which allows him to navigate different healthcare systems and manage a wide range of conditions with confidence. Patients value his calm, structured approach, clear explanations and evidence-based decision-making.

Online consultations with Dr. Lokchiri are suitable for many situations when someone needs quick medical guidance, reassurance or a clear next step. Common reasons for booking include:

  • fever, chills, fatigue and viral symptoms
  • cough, sore throat, nasal congestion, breathing discomfort
  • bronchitis and mild asthma flare-ups
  • nausea, diarrhoea, abdominal pain, digestive infections
  • rashes, allergic reactions, redness, insect bites
  • muscle or joint pain, mild injuries, sprains
  • headache, dizziness, migraine symptoms
  • stress-related symptoms, sleep disturbances
  • questions about test results and treatment plans
  • management of chronic conditions in stable phases
Many patients reach out when symptoms appear suddenly and cause concern, when a child becomes unwell unexpectedly, when a rash changes or spreads, or when it’s unclear whether an in-person examination is necessary. His emergency medicine background is particularly valuable online, helping patients understand risk levels, identify warning signs and choose safe next steps.

Some situations are not suitable for online care. If a patient has loss of consciousness, severe chest pain, uncontrolled bleeding, seizures, major trauma or symptoms suggesting a stroke or heart attack, he will advise seeking immediate local emergency services. This improves safety and ensures patients receive the right level of care.

Dr. Lokchiri’s professional training includes:

  • Advanced Trauma Life Support (ATLS)
  • Basic and Advanced Cardiac Life Support (BLS/ACLS)
  • Pediatric Advanced Life Support (PALS)
  • Prehospital Trauma Life Support (PHTLS)
  • eFAST and critical care transthoracic echocardiography
  • aviation medicine
He is an active member of several professional organisations, including the French Society of Emergency Medicine (SFMU), the French Association for Emergency Physicians (AMUF) and the Swiss Society of Emergency and Rescue Medicine (SGNOR). In consultations, he works with clarity and precision, helping patients understand their symptoms, possible risks and the safest treatment options.
Camera Book a video appointment
€58
0.0 (6)
Doctor

Daniel Cichi

Family medicine 24 years exp.

Dr Daniel Cichi is a family medicine doctor with over 20 years of clinical experience. He provides online consultations for adults, supporting patients with acute symptoms, chronic conditions, and everyday health concerns that require timely medical guidance. His background includes work in emergency care, ambulance services, and family medicine, which allows him to assess symptoms quickly, identify warning signs, and help patients choose the safest next steps – whether that means home care, treatment adjustment, or in-person evaluation. Patients commonly consult Dr Daniel Cichi for: 

  • acute symptoms: fever, infections, flu-like illness, cough, sore throat, shortness of breath;
  • chest discomfort, palpitations, dizziness, fatigue, and blood pressure concerns;
  • digestive problems: abdominal pain, nausea, diarrhoea, constipation, reflux;
  • sexually transmitted infections, erectile dysfunction;
  • muscle, joint, and back pain, minor injuries, post-traumatic symptoms;
  • chronic conditions: hypertension, diabetes, high cholesterol, thyroid disorders, weight loss, hair loss;
  • review and interpretation of lab tests, imaging reports, and medical documents;
  • medication review and treatment adjustment;
  • medical advice while travelling or living abroad;
  • second opinions and guidance on whether in-person care is needed.

Dr Cichi’s consultations are structured and practical. He focuses on clear explanations, risk assessment, and actionable recommendations, helping patients understand their symptoms and make informed decisions about their health.

Camera Book a video appointment
€55
5.0 (32)
Doctor

Dmytro Horobets

Family medicine 7 years exp.

Dr. Dmytro Horobets is a licensed family medicine physician in Poland, specialising in endocrinology, diabetology, obesity management, gastroenterology, pediatrics, general surgery, and pain medicine. He offers online consultations for adults and children, providing personalised medical support for a wide range of acute and chronic health concerns.

Areas of expertise:

  • Endocrinology: diabetes type 1 and type 2, prediabetes, thyroid disorders, metabolic syndrome, hormonal imbalance.
  • Obesity medicine: structured weight management plans, nutritional counselling, obesity-related health risks.
  • Gastroenterology: acid reflux (GERD), gastritis, irritable bowel syndrome (IBS), liver and biliary conditions.
  • Pediatric care: infections, respiratory symptoms, digestive issues, growth and development monitoring.
  • General surgery support: pre- and post-surgical consultations, wound care, rehabilitation.
  • Pain management: chronic and acute pain, back pain, joint pain, post-traumatic pain syndromes.
  • Cardiovascular health: hypertension, cholesterol control, risk assessment for heart disease.
  • Preventive medicine: regular check-ups, health screenings, long-term management of chronic conditions.

Dr. Horobets combines evidence-based medicine with a patient-centred approach. He carefully evaluates each patient’s medical history and symptoms, offering clear explanations and structured treatment plans adapted to individual needs.

Whether you need help managing diabetes, tackling weight-related health issues, interpreting lab results, or receiving general family medicine support, Dr. Horobets provides professional online care tailored to your specific health goals.

Camera Book a video appointment
€60

Frequently Asked Questions

Is a prescription required for MONTELUKAST RATIOPHARM 5 mg CHEWABLE TABLETS?
MONTELUKAST RATIOPHARM 5 mg CHEWABLE TABLETS requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in MONTELUKAST RATIOPHARM 5 mg CHEWABLE TABLETS?
The active ingredient in MONTELUKAST RATIOPHARM 5 mg CHEWABLE TABLETS is montelukast. This information helps identify medicines with the same composition but different brand names.
How much does MONTELUKAST RATIOPHARM 5 mg CHEWABLE TABLETS cost in pharmacies?
The average pharmacy price for MONTELUKAST RATIOPHARM 5 mg CHEWABLE TABLETS is around 21.06 EUR. Prices may vary depending on the manufacturer and dosage form.
Who manufactures MONTELUKAST RATIOPHARM 5 mg CHEWABLE TABLETS?
MONTELUKAST RATIOPHARM 5 mg CHEWABLE TABLETS is manufactured by Teva Pharma S.L.U.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of MONTELUKAST RATIOPHARM 5 mg CHEWABLE TABLETS online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether MONTELUKAST RATIOPHARM 5 mg CHEWABLE TABLETS is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to MONTELUKAST RATIOPHARM 5 mg CHEWABLE TABLETS?
Other medicines with the same active substance (montelukast) include MONKASTA 10 mg FILM-COATED TABLETS, MONKASTA 4 mg CHEWABLE TABLETS, MONKASTA 5 mg CHEWABLE TABLETS. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media